• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers.健康成年志愿者体内克拉霉素和阿奇霉素的肺内稳态浓度。
Antimicrob Agents Chemother. 1997 Jun;41(6):1399-402. doi: 10.1128/AAC.41.6.1399.
2
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.阿奇霉素、克拉霉素、环丙沙星和头孢呋辛在志愿者体内的单剂量肺内药代动力学
Antimicrob Agents Chemother. 1996 Jul;40(7):1617-22. doi: 10.1128/AAC.40.7.1617.
3
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin.克拉霉素与阿奇霉素的支气管肺药代动力学比较。
Antimicrob Agents Chemother. 1996 Oct;40(10):2375-9. doi: 10.1128/AAC.40.10.2375.
4
Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.克拉霉素缓释片在正常健康成年受试者中的稳态血浆和支气管肺特征。
J Antimicrob Chemother. 2003 Sep;52(3):450-6. doi: 10.1093/jac/dkg355. Epub 2003 Jul 29.
5
Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.健康成年人静脉注射左氧氟沙星和阿奇霉素后的稳态血浆及支气管肺浓度。
Antimicrob Agents Chemother. 2003 Aug;47(8):2450-7. doi: 10.1128/AAC.47.8.2450-2457.2003.
6
Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.大环内酯类抗菌药物克拉霉素和阿奇霉素在肺上皮衬液和肺泡巨噬细胞中的分布特征。用于治疗呼吸道感染。
Biopharm Drug Dispos. 2011 Oct;32(7):389-97. doi: 10.1002/bdd.767. Epub 2011 Aug 2.
7
Pulmonary disposition of erythromycin, azithromycin, and clarithromycin in foals.红霉素、阿奇霉素和克拉霉素在驹中的肺部处置情况。
J Vet Pharmacol Ther. 2007 Apr;30(2):109-15. doi: 10.1111/j.1365-2885.2007.00833.x.
8
Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses.健康志愿者口服五剂阿奇霉素后的肺内药代动力学
Antimicrob Agents Chemother. 1996 Nov;40(11):2582-5. doi: 10.1128/AAC.40.11.2582.
9
Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults.老年人中莫西沙星、左氧氟沙星和阿奇霉素的肺内稳态浓度。
Chest. 2004 Mar;125(3):965-73. doi: 10.1378/chest.125.3.965.
10
Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects.健康成年受试者中左氧氟沙星和环丙沙星的稳态血浆浓度及肺内浓度。
Chest. 2001 Apr;119(4):1114-22. doi: 10.1378/chest.119.4.1114.

引用本文的文献

1
Plasma and intrapulmonary pharmacokinetics of cefepime and taniborbactam in healthy adult participants.头孢吡肟和他尼硼巴坦在健康成年受试者中的血浆及肺内药代动力学
Antimicrob Agents Chemother. 2025 Jul 2;69(7):e0049325. doi: 10.1128/aac.00493-25. Epub 2025 Jun 6.
2
Poor efficacy of the combination of clarithromycin, amikacin, and cefoxitin against Mycobacterium abscessus in the hollow fiber infection model.在中空纤维感染模型中,克拉霉素、阿米卡星和头孢西丁联合使用对脓肿分枝杆菌的疗效不佳。
Ann Clin Microbiol Antimicrob. 2025 Jan 30;24(1):10. doi: 10.1186/s12941-025-00776-w.
3
Intrapulmonary pharmacokinetics of SPR719 following oral administration of SPR720 to healthy volunteers.健康志愿者口服 SPR720 后 SPK719 的肺部药代动力学。
Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0110324. doi: 10.1128/aac.01103-24. Epub 2024 Oct 1.
4
Minimum inhibitory concentrations of azithromycin in clinical isolates of complex in Japan.日本临床分离株中阿奇霉素的最低抑菌浓度。
Microbiol Spectr. 2024 Jun 4;12(6):e0021824. doi: 10.1128/spectrum.00218-24. Epub 2024 Apr 30.
5
Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial Lining Fluid, and Alveolar Macrophages following Intravenous Administration to Healthy Adult Subjects.SPR206 在健康成年受试者静脉给药后的血浆、肺上皮衬液和肺泡巨噬细胞中的药代动力学。
Antimicrob Agents Chemother. 2023 Jul 18;67(7):e0042623. doi: 10.1128/aac.00426-23. Epub 2023 Jun 20.
6
Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review-Part II.重症监护病房患者抗菌药物的组织穿透性:系统评价 - 第二部分
Antibiotics (Basel). 2022 Sep 3;11(9):1193. doi: 10.3390/antibiotics11091193.
7
Azithromycin for COVID-19: More Than Just an Antimicrobial?阿奇霉素用于治疗新冠肺炎:作用岂止抗菌?
Clin Drug Investig. 2020 Aug;40(8):683-686. doi: 10.1007/s40261-020-00933-3.
8
In vitro activity and pharmacodynamic/pharmacokinetic parameters of clarithromycin and azithromycin: why they matter in the treatment of respiratory tract infections.克拉霉素和阿奇霉素的体外活性及药效学/药代动力学参数:它们在呼吸道感染治疗中为何重要。
Infect Drug Resist. 2019 Mar 8;12:585-596. doi: 10.2147/IDR.S187226. eCollection 2019.
9
Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects.健康成年受试者静脉注射 ETX2514SUL 后 ETX2514 和舒巴坦的血浆和肺内浓度。
Antimicrob Agents Chemother. 2018 Oct 24;62(11). doi: 10.1128/AAC.01089-18. Print 2018 Nov.
10
Plasma and Intrapulmonary Concentrations of Cefepime and Zidebactam following Intravenous Administration of WCK 5222 to Healthy Adult Subjects.健康成年受试者静脉给予 WCK 5222 后头孢吡肟和齐多夫定的血浆和肺内浓度。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00682-18. Print 2018 Aug.

本文引用的文献

1
Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses.健康志愿者口服五剂阿奇霉素后的肺内药代动力学
Antimicrob Agents Chemother. 1996 Nov;40(11):2582-5. doi: 10.1128/AAC.40.11.2582.
2
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin.克拉霉素与阿奇霉素的支气管肺药代动力学比较。
Antimicrob Agents Chemother. 1996 Oct;40(10):2375-9. doi: 10.1128/AAC.40.10.2375.
3
Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.阿奇霉素与克拉霉素治疗下呼吸道感染患者的比较。
J Antimicrob Chemother. 1993 Jun;31 Suppl E:153-62. doi: 10.1093/jac/31.suppl_e.153.
4
Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association.成人社区获得性肺炎初始管理指南:诊断、严重程度评估及初始抗菌治疗。美国胸科学会。美国肺脏协会医学部。
Am Rev Respir Dis. 1993 Nov;148(5):1418-26. doi: 10.1164/ajrccm/148.5.1418.
5
Penetration of clarithromycin into lung tissues from patients undergoing lung resection.肺切除患者中克拉霉素在肺组织中的渗透情况。
Antimicrob Agents Chemother. 1994 Apr;38(4):876-8. doi: 10.1128/AAC.38.4.876.
6
The levels of clarithromycin and its 14-hydroxy metabolite in the lung.肺中克拉霉素及其14 - 羟基代谢物的水平。
Eur Respir J. 1994 Jul;7(7):1275-80. doi: 10.1183/09031936.94.07071275.
7
Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin.克拉霉素和红霉素的肺内药代动力学。
Antimicrob Agents Chemother. 1995 Feb;39(2):334-8. doi: 10.1128/AAC.39.2.334.
8
Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.使用尿素作为稀释标志物通过灌洗回收的上皮衬液体积的估计。
J Appl Physiol (1985). 1986 Feb;60(2):532-8. doi: 10.1152/jappl.1986.60.2.532.
9
Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans.14-羟基克拉霉素(克拉霉素在人体内的主要代谢产物)增强了克拉霉素对流感嗜血杆菌的体外和体内活性。
Antimicrob Agents Chemother. 1990 Jul;34(7):1407-13. doi: 10.1128/AAC.34.7.1407.
10
Azithromycin concentrations at the sites of pulmonary infection.肺部感染部位的阿奇霉素浓度。
Eur Respir J. 1990 Sep;3(8):886-90.

健康成年志愿者体内克拉霉素和阿奇霉素的肺内稳态浓度。

Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers.

作者信息

Rodvold K A, Gotfried M H, Danziger L H, Servi R J

机构信息

College of Pharmacy, University of Illinois, Chicago 60612, USA.

出版信息

Antimicrob Agents Chemother. 1997 Jun;41(6):1399-402. doi: 10.1128/AAC.41.6.1399.

DOI:10.1128/AAC.41.6.1399
PMID:9174209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC163925/
Abstract

The steady-state concentrations of clarithromycin and azithromycin in plasma were compared with concomitant concentrations in epithelial lining fluid (ELF) and alveolar macrophages (AM) obtained in intrapulmonary samples during bronchoscopy and bronchoalveolar lavage from 40 healthy, nonsmoking adult volunteers. Mean plasma clarithromycin, 14-(R)-hydroxyclarithromycin, and azithromycin concentrations were similar to those previously reported. Clarithromycin was extensively concentrated in ELF (range of mean +/- standard deviation concentrations, 34.4 +/- 29.3 microg/ml at 4 h to 4.6 +/- 3.7 microg/ml at 24 h) and AM (480 +/- 533 microg/ml at 4 h to 99 +/- 50 microg/ml at 24 h). The concentrations of azithromycin in ELF were 1.01 +/- 0.45 microg/ml at 4 h to 1.22 +/- 0.59 microg/ml at 24 h, and those in AM were 42.7 +/- 28.7 microg/ml at 4 h to 41.7 +/- 12.1 microg/ml at 24 h. The concentrations of 14-(R)-hydroxyclarithromycin in the AM ranged from 89.3 +/- 52.8 microg/ml at 4 h to 31.3 +/- 17.7 microg/ml at 24 h. During the period of 24 h after drug administration, azithromycin and clarithromycin achieved mean concentrations in ELF and AM higher than the concomitant concentrations in plasma.

摘要

对40名健康、不吸烟的成年志愿者在支气管镜检查和支气管肺泡灌洗期间获取的肺内样本中的上皮衬液(ELF)和肺泡巨噬细胞(AM)中的克拉霉素和阿奇霉素稳态浓度与血浆中的伴随浓度进行了比较。血浆中克拉霉素、14-(R)-羟基克拉霉素和阿奇霉素的平均浓度与先前报道的相似。克拉霉素在ELF中大量富集(平均±标准差浓度范围,4小时时为34.4±29.3μg/ml至24小时时为4.6±3.7μg/ml),在AM中也大量富集(4小时时为480±533μg/ml至24小时时为99±50μg/ml)。阿奇霉素在ELF中的浓度在4小时时为1.01±0.45μg/ml至24小时时为1.22±0.59μg/ml,在AM中的浓度在4小时时为42.7±28.7μg/ml至24小时时为41.7±12.1μg/ml。AM中14-(R)-羟基克拉霉素的浓度范围为4小时时89.3±52.8μg/ml至24小时时31.3±17.7μg/ml。在给药后的24小时内,阿奇霉素和克拉霉素在ELF和AM中的平均浓度高于血浆中的伴随浓度。